174 related articles for article (PubMed ID: 11234878)
1. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines.
Bhattacharya A; Lakka SS; Mohanam S; Boyd D; Rao JS
Clin Cancer Res; 2001 Feb; 7(2):267-76. PubMed ID: 11234878
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the uPA gene in various grades of human glioma cells.
Lakka SS; Bhattacharya A; Mohanam S; Boyd D; Rao JS
Int J Oncol; 2001 Jan; 18(1):71-9. PubMed ID: 11115541
[TBL] [Abstract][Full Text] [Related]
3. Requirement of TGF-beta receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress-activated protein kinases (Sapks) for TGF-beta up-regulation of the urokinase-type plasminogen activator receptor.
Yue J; Sun B; Liu G; Mulder KM
J Cell Physiol; 2004 May; 199(2):284-92. PubMed ID: 15040011
[TBL] [Abstract][Full Text] [Related]
4. Aspirin upregulates expression of urokinase type plasminogen activator receptor (uPAR) gene in human colon cancer cells through AP1.
Jamaluddin MS
Biochem Biophys Res Commun; 2006 Sep; 348(2):618-27. PubMed ID: 16893520
[TBL] [Abstract][Full Text] [Related]
5. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
[TBL] [Abstract][Full Text] [Related]
6. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
[TBL] [Abstract][Full Text] [Related]
7. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
9. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic phorbol ester treatment on protein kinase C activity, content, and gene expression in the human monoblastoid U937 cell.
Ways DK; Qin W; Garris TO; Chen J; Hao E; Cooper DR; Usala SJ; Parker PJ; Cook PP
Cell Growth Differ; 1994 Feb; 5(2):161-9. PubMed ID: 8180129
[TBL] [Abstract][Full Text] [Related]
12. Glioma cells deficient in urokinase plaminogen activator receptor expression are susceptible to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.
Krishnamoorthy B; Darnay B; Aggarwal B; Dinh DH; Kouraklis G; Olivero WC; Gujrati M; Rao JS
Clin Cancer Res; 2001 Dec; 7(12):4195-201. PubMed ID: 11751520
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of urokinase-type plasminogen activator receptor by cyclic AMP in PL-21 human myeloid leukemia cells: comparison with the regulation by phorbol myristate acetate.
Niiya K; Ozawa T; Tsuzawa T; Ueshima S; Matsuo O; Sakuragawa N
Thromb Haemost; 1998 Mar; 79(3):574-8. PubMed ID: 9531044
[TBL] [Abstract][Full Text] [Related]
14. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.
Lengye E; Singh B; Gum R; Nerlov C; Sabichi A; Birrer M; Boyd D
Oncogene; 1995 Dec; 11(12):2639-48. PubMed ID: 8545121
[TBL] [Abstract][Full Text] [Related]
15. Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia.
Maity A; Solomon D
Exp Cell Res; 2000 Mar; 255(2):250-7. PubMed ID: 10694440
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the rat urokinase plasminogen activator receptor promoter in PC12 cells.
Su F; Kozak KR; Herschman H; Reddy ST; Farias-Eisner R
J Neurosci Res; 2007 Jul; 85(9):1952-8. PubMed ID: 17455298
[TBL] [Abstract][Full Text] [Related]
17. Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2alpha-related factor binding to different regions of the urokinase receptor gene in resected colorectal cancers.
Schewe DM; Biller T; Maurer G; Asangani IA; Leupold JH; Lengyel ER; Post S; Allgayer H
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8538-48. PubMed ID: 16361535
[TBL] [Abstract][Full Text] [Related]
18. A urokinase receptor mRNA binding protein-mRNA interaction regulates receptor expression and function in human pleural mesothelioma cells.
Shetty S; Idell S
Arch Biochem Biophys; 1998 Aug; 356(2):265-79. PubMed ID: 9705217
[TBL] [Abstract][Full Text] [Related]
19. Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells.
Baek MK; Park JS; Park JH; Kim MH; Kim HD; Bae WK; Chung IJ; Shin BA; Jung YD
Cancer Lett; 2010 Apr; 290(1):123-8. PubMed ID: 19782465
[TBL] [Abstract][Full Text] [Related]
20. Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences.
Adachi Y; Chandrasekar N; Kin Y; Lakka SS; Mohanam S; Yanamandra N; Mohan PM; Fuller GN; Fang B; Fueyo J; Dinh DH; Olivero WC; Tamiya T; Ohmoto T; Kyritsis AP; Rao JS
Oncogene; 2002 Jan; 21(1):87-95. PubMed ID: 11791179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
